Current roles
From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.
No current S&P 500 role.
Past roles
“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.
Sits alongside
People who currently share a board or management team with this person.
No current colleagues on record.
Open-market trades
Purchases and sales reported on Form 4 at S&P 500 companies.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 15, 2022 | CVS | Sale | 36,490 | $98.24 | $3.6M |
| Dec 15, 2022 | CVS | Sale | 100,976 | $98.40 | $9.9M |
| Jun 28, 2022 | CVS | Sale | 50,502 | $95.00 | $4.8M |
| Jun 28, 2022 | CVS | Sale | 49,279 | $95.00 | $4.7M |
| Jun 28, 2022 | CVS | Sale | 38,873 | $95.00 | $3.7M |
| Mar 15, 2022 | CVS | Sale | 51,361 | $105.00 | $5.4M |
| May 10, 2021 | CVS | Sale | 109,469 | $86.00 | $9.4M |
| Apr 21, 2021 | CVS | Sale | 101,003 | $77.00 | $7.8M |
| Apr 21, 2021 | CVS | Sale | 2,420 | $77.00 | $186K |
| Mar 29, 2021 | CVS | Sale | 62,943 | $76.15 | $4.8M |
| Mar 19, 2021 | CVS | Sale | 49,211 | $74.15 | $3.6M |
| Oct 2, 2017 | CVS | Sale | 20,547 | $81.17 | $1.7M |
| Sep 11, 2017 | CVS | Sale | 49,174 | $79.61 | $3.9M |
| Sep 11, 2017 | CVS | Sale | 41,093 | $79.61 | $3.3M |
SEC reporting-owner ID (CIK) 1412221 · all filings on EDGAR